Zhifeng Liu Selected Research

ferulic acid (sodium ferulate)

8/2017	Anti-exudation effects of sodium ferulate and oxymatrine combination via modulation of aquaporin 1.
1/2015	The Protective Effect of Sodium Ferulate and Oxymatrine Combination on Paraquat-induced Lung Injury.
5/2014	Protective effects of the combination of sodium ferulate and oxymatrine on cecal ligation and puncture-induced sepsis in mice.
6/2012	The effects of the combination of sodium ferulate and oxymatrine on lipopolysaccharide-induced acute lung injury in mice.
10/2011	The synergistic anti-inflammatory effect of the combination of sodium ferulate and oxymatrine and its modulation on inflammation-associated mediators in RAW 264.7 cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zhifeng Liu Research Topics

Disease

17	Heat Stroke (Heatstroke) 01/2022 - 05/2011
7	Neoplasms (Cancer) 01/2022 - 11/2013
5	COVID-19 06/2021 - 01/2020
5	Squamous Cell Carcinoma of Head and Neck 01/2021 - 01/2020
5	Inflammation (Inflammations) 01/2019 - 10/2011
5	Brain Ischemia (Cerebral Ischemia) 01/2018 - 01/2008
4	Sepsis (Septicemia) 05/2022 - 05/2014
4	Brain Injuries (Brain Injury) 02/2022 - 11/2016
4	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 01/2020
4	Glioma (Gliomas) 11/2021 - 11/2013
4	Carcinogenesis 11/2021 - 09/2018
4	Ischemia 06/2017 - 03/2009
3	Traumatic Brain Injuries (Traumatic Brain Injury) 07/2022 - 11/2016
3	Brain Edema (Cerebral Edema) 02/2022 - 06/2017
3	Heart Arrest (Cardiac Arrest) 02/2022 - 09/2017
3	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 07/2015
3	Hypoxia (Hypoxemia) 01/2019 - 12/2010
3	Acute Lung Injury 01/2018 - 06/2012
2	Rhabdomyolysis 01/2022 - 12/2021
2	Disseminated Intravascular Coagulation 01/2022 - 01/2021
2	Critical Illness (Critically Ill) 12/2021 - 06/2021
2	Infections 06/2021 - 01/2005
2	Fever (Fevers) 06/2021 - 01/2021
2	Myocardial Infarction 01/2021 - 02/2010
2	Diarrhea 01/2020 - 01/2019
2	Hemorrhage 01/2019 - 03/2015
2	Lung Injury 10/2018 - 01/2015
2	Ventricular Fibrillation 10/2018 - 09/2017
2	Heart Diseases (Heart Disease) 09/2018 - 10/2011
2	Shock 09/2017 - 05/2014
2	Edema (Dropsy) 08/2017 - 10/2011
2	Pulmonary Edema 01/2015 - 05/2014
2	Body Weight (Weight, Body) 04/2013 - 06/2009
2	Myocardial Ischemia (Ischemic Heart Diseases) 06/2011 - 02/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2009 - 06/2009
2	Cerebral Infarction 03/2009 - 09/2008
1	progressive familial intrahepatic 1 Cholestasis 11/2022
1	Cholestasis 11/2022
1	Asphyxia (Suffocation) 02/2022
1	Hepatic Encephalopathy 10/2021
1	Hypotension (Low Blood Pressure) 06/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 06/2021
1	Hyperthermia 01/2021

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2005
6	oxymatrineIBA 08/2017 - 10/2011
5	Interleukin-6 (Interleukin 6)IBA 06/2021 - 05/2014
5	C-Reactive ProteinIBA 01/2021 - 05/2014
5	ferulic acid (sodium ferulate)IBA 08/2017 - 10/2011
4	QuercetinIBA 07/2022 - 11/2016
4	Messenger RNA (mRNA)IBA 12/2020 - 01/2005
4	AntioxidantsIBA 12/2016 - 01/2008
3	Biological ProductsIBA 11/2021 - 06/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 07/2014
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021 - 02/2010
3	Acetic Acid (Vinegar)FDA LinkGeneric 08/2017 - 09/2010
3	Therapeutic UsesIBA 06/2017 - 06/2011
3	Malondialdehyde (Propanedial)IBA 01/2015 - 02/2010
3	EndotoxinsIBA 03/2013 - 05/2011
2	fibrin fragment D (D-dimer)IBA 01/2022 - 12/2021
2	Pharmaceutical PreparationsIBA 01/2022 - 10/2011
2	6-methyladenineIBA 11/2021 - 01/2020
2	BilirubinIBA 10/2021 - 10/2014
2	Histones (Histone)IBA 09/2021 - 03/2015
2	LigandsIBA 12/2020 - 01/2019
2	LipopolysaccharidesIBA 01/2020 - 06/2012
2	Circular RNAIBA 01/2020 - 01/2019
2	CalpainIBA 01/2020 - 12/2016
2	CytokinesIBA 01/2019 - 02/2015
2	urinastatin (MR 20)IBA 01/2019 - 01/2018
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 12/2018 - 01/2017
2	salicylhydroxamic acid (SHAM)IBA 10/2018 - 04/2013
2	Neuroprotective AgentsIBA 06/2018 - 03/2009
2	Propofol (Diprivan)FDA LinkGeneric 01/2018 - 03/2013
2	InterferonsIBA 08/2017 - 05/2014
2	XuebijingIBA 02/2015 - 04/2013
2	akebia saponin DIBA 12/2010 - 02/2010
2	Caspase 3 (Caspase-3)IBA 12/2010 - 01/2005
2	TriterpenesIBA 02/2010 - 04/2009
2	phenolic acidIBA 09/2009 - 06/2009
2	3,4-dihydroxyphenyllactic acidIBA 09/2009 - 06/2009
1	gamma-Glutamyltransferase (gamma-Glutamyl Transpeptidase)IBA 11/2022
1	Antisense OligonucleotidesIBA 11/2022
1	Member 11 Subfamily B ATP Binding Cassette TransporterIBA 11/2022
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 11/2022
1	ErbB Receptors (EGF Receptor)IBA 05/2022
1	MyoglobinIBA 01/2022
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 11/2021
1	Indicators and Reagents (Reagents)IBA 01/2021
1	ceric oxide (cerium dioxide)IBA 01/2021

Therapy/Procedure

5	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 06/2009
5	Therapeutics 01/2021 - 02/2015
3	Cardiopulmonary Resuscitation (CPR) 02/2022 - 09/2017
3	Critical Care (Surgical Intensive Care) 01/2022 - 01/2021
3	Immunotherapy 01/2021 - 11/2020
2	Resuscitation 02/2022 - 09/2017
2	Length of Stay 01/2022 - 03/2014
2	Ligation 01/2018 - 05/2014
1	Esophagectomy 01/2022
1	Continuous Renal Replacement Therapy 06/2021
1	Catheters 06/2021